NASDAQ:HCWB HCW Biologics (HCWB) News Today $1.56 -0.09 (-5.45%) (As of 12:41 PM ET) Add Compare Share Share Today's Range$1.55▼$1.6450-Day Range$1.29▼$1.6552-Week Range$1.08▼$2.79Volume10,051 shsAverage Volume18,953 shsMarket Capitalization$55.99 millionP/E RatioN/ADividend YieldN/APrice Target$8.50 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address HCWB Media Mentions By Week HCWB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCWB News Sentiment▼1.090.78▲Average Medical News Sentiment HCWB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCWB Articles This Week▼61▲HCWB Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRebecca Byam Acquires 20,000 Shares of HCW Biologics Inc. (NASDAQ:HCWB) Stockamericanbankingnews.com - May 27 at 6:58 AMHCW Biologics Inc. (NASDAQ:HCWB) CFO Rebecca Byam Purchases 33,450 Sharesamericanbankingnews.com - May 26 at 6:38 AMFinancial Comparison: HCW Biologics (HCWB) vs. Its Competitorsamericanbankingnews.com - May 16 at 3:20 AMAnalysts Offer Insights on Healthcare Companies: Syros Pharmaceuticals (SYRS) and HCW Biologics (HCWB)markets.businessinsider.com - May 10 at 7:54 PMHCW Biologics First Quarter 2023 Earnings: US$0.14 loss per share (vs US$0.057 loss in 1Q 2022)finance.yahoo.com - May 10 at 9:52 AM10-Q: HCW BIOLOGICS INC.marketwatch.com - May 9 at 11:13 PMRecap: HCW Biologics Q1 Earningsmsn.com - May 9 at 1:10 PMHCW Biologics: Q1 Earnings Insightsmsn.com - May 9 at 1:10 PMHCW Biologics, Inc: HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlightsfinanznachrichten.de - May 9 at 8:10 AMHCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlightsfinance.yahoo.com - May 9 at 8:10 AMHCW Biologics (HCWB) and Its Rivals Critical Comparisonamericanbankingnews.com - May 9 at 2:36 AMHCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loanfinance.yahoo.com - April 27 at 7:57 AMEF Hutton Acquisition Co. I Reaffirms "Buy" Rating for HCW Biologics (NASDAQ:HCWB)americanbankingnews.com - April 22 at 5:54 AMHCW Biologics Inc. (NASDAQ:HCWB) Short Interest Updateamericanbankingnews.com - April 20 at 6:22 AMEF Hutton Reiterates HCW Biologics (HCWB) Buy Recommendationmsn.com - April 19 at 6:39 PMHCW Biologics (HCWB) versus Its Competitors Critical Analysisamericanbankingnews.com - April 17 at 9:06 AMHCW Biologics Poster Presentation at AACR Annual Meeting 2023finance.yahoo.com - April 13 at 10:46 AMHCW Biologics, Inc: A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseasesfinanznachrichten.de - April 5 at 3:13 PMMaxim Group Remains a Buy on HCW Biologics (HCWB)markets.businessinsider.com - April 5 at 10:12 AMA Novel Immunotherapeutic Approach to Treating Aging-Associated Diseasesfinance.yahoo.com - April 3 at 10:12 AMHCW Biologics' (HCWB) "Buy" Rating Reiterated at EF Hutton Acquisition Co. Iamericanbankingnews.com - April 3 at 2:38 AMHCW Biologics (HCWB) Receives a Buy from Maxim Groupmarkets.businessinsider.com - March 31 at 12:14 PMHCW Biologics, Inc: HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlightsfinanznachrichten.de - March 29 at 7:29 PMJonesTrading Reaffirms Their Buy Rating on HCW Biologics (HCWB)markets.businessinsider.com - March 29 at 1:49 PMLooking Into HCW Biologics's Return On Capital Employedmsn.com - March 29 at 1:49 PMHCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlightsfinance.yahoo.com - March 28 at 6:05 PMHCW Biologics Stock (NASDAQ:HCWB), Dividendsbenzinga.com - March 26 at 8:22 AMThe Global Biologics CDMO Market is forecast to grow by $13.26 bn during 2022-2027, accelerating at a CAGR of 13.97% during the forecast periodbenzinga.com - March 1 at 7:04 PMWound Care Biologics Market Size 2023 with Top Significant Players, SWOT Analysis, End-User Industries and Segments Forecast 2029marketwatch.com - February 19 at 10:31 PMBullish HCW Biologics Inc. (NASDAQ:HCWB) insiders filled their treasuries with US$687k worth of stock over last yearfinance.yahoo.com - February 13 at 8:52 AMHCW Biologics (NASDAQ:HCWB) shareholders have endured a 18% loss from investing in the stock a year agofinance.yahoo.com - January 3 at 12:31 PMHCW Biologics Enters CRADA with National Cancer Institutefinance.yahoo.com - December 8 at 6:29 PMHCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ Platformfinance.yahoo.com - December 7 at 8:58 AMHCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ Platformfinance.yahoo.com - December 7 at 8:58 AMHCW Biologics Reports Third Quarter 2022 Financial Results And Recent Business Highlightsfinance.yahoo.com - November 8 at 9:00 AMMasonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meetingfinance.yahoo.com - November 8 at 9:00 AMSamsung Biologics obtains three global ISO certificationsyahoo.com - October 15 at 9:07 PMInvestors in HCW Biologics (NASDAQ:HCWB) have unfortunately lost 15% over the last yearnasdaq.com - October 15 at 10:15 AMHCW Biologics Inc. (HCWB)finance.yahoo.com - September 23 at 6:20 PMTuesday 8/30 Insider Buying Report: HCWB, OSURnasdaq.com - August 30 at 5:10 PMTrade Alert: The Chief Financial Officer Of HCW Biologics Inc. (NASDAQ:HCWB), Rebecca Byam, Has Just Spent US$230k Buying 58% More Sharesfinance.yahoo.com - August 28 at 1:11 PMHere's Why We're Not Too Worried About HCW Biologics' (NASDAQ:HCWB) Cash Burn Situationnasdaq.com - August 17 at 6:43 PMHCW Biologics Reports Second Quarter 2022 Financial Results And Recent Business Highlightsfinance.yahoo.com - August 12 at 8:12 AMU.S. Patent Issued to HCW Biologics for Foundational Platform Technologyfinance.yahoo.com - August 3 at 7:52 AMHCW Biologics (NASDAQ:HCWB) shareholders have endured a 57% loss from investing in the stock a year agofinance.yahoo.com - July 27 at 10:36 AMHCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 – 25, 2022finance.yahoo.com - May 23 at 8:18 AMHCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 – 25, 2022finance.yahoo.com - May 23 at 8:18 AMHCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlightsfinance.yahoo.com - May 13 at 6:01 PMHCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary and Versatile TOBI™ Platform At the 105th Annual Meeting of the American Association of Immunologistsfinance.yahoo.com - May 5 at 11:10 AMHCW Biologics' CEO Hing C. Wong, Ph.D., to be Featured Speaker at the Third Annual International Conference on Cell and Experimental Biology 2022stockhouse.com - April 19 at 8:06 AM Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Enochian Biosciences News Today ASLAN Pharmaceuticals News Today Assembly Biosciences News Today Lantern Pharma News Today LifeVantage News Today Mainz Biomed News Today Abeona Therapeutics News Today IO Biotech News Today Gain Therapeutics News Today Carisma Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:HCWB) was last updated on 5/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.